
Tailoring Immunosuppressive Regimen with Certican ®

Abbreviations:
CNI, Calcineurin inhibitors; KDIGO, Kidney Disease: Improving Global Outcomes; EBP, evidence-based practice; IS, immunosuppressant; BMI, body mass index; rCNI, reduced-exposure calcineurin inhibitor; KT, kidney transplant; NODAT, new-onset diabetes after transplantation; CMV, cytomegalovirus; 95% CI, 95% confidence interval
References:
1. Kasiske BL, et al. Am J Transplant. 2009;9 Suppl 3:S1-155; 2. Pascual J, et al. Transplant Rev. 2019;33(4):191-199; 3. Baker RJ, et al. BMC Nephrol. 2017;18(1):174; 4. Kim HD, et al. Ann Transplant. 2021;26:e927984. 5. Cibrik, Diane, et al. Transplantation. 2013;95(7):933–942. 6. Berger SP, et al. Am J Transplant. 2019;19(11):3018-3034. 7. Lim WH, et al. Kidney Int. 2017;91(4):954-963. 8. Shihab FS, et al. Clin Transplant .2013: 27: 217–226

20 Pasir Panjang Road #10-25/28 Mapletree Business City (West Tower) Singapore 117439
Phone: +65 6722 6010
FOR HEALTHCARE PROFESSIONALS ONLY
APPROVAL CODE
